Branded Medicines & Vaccine Developers

Own drug developers whose core businesses commercialize proprietary medicines and vaccines rather than finance AI infrastructure. The approaching earnings reports offer a timely test of prescription demand, pipeline progress and patent-replacement strategies. Established franchises diversify the basket across therapeutic areas, although clinical setbacks, pricing pressure and patent expirations remain material risks. Launch basket (equal weight): ABBV, AMGN, MRK, LLY, JNJ, MRNA, GILD Rules: 1. No inverse, leveraged or volatility ETFs. 2. Only names tradable at the enrolled brokers (Moomoo): no OTC listings, no dead tickers, nothing on the refused list.